Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Type 2 diabetes mellitus (T2DM) is a progressive and multifactorial cardiometabolic disorder. Almost half of adults with diabetes fail to achieve their recommended glucose control target. This has prompted some clinicians to advocate the use of more intensive initial therapy, including the use of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Sayf A, Aroda, Vanita R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367741/
https://www.ncbi.nlm.nih.gov/pubmed/28356718
http://dx.doi.org/10.2147/DDDT.S121899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367741/
https://www.ncbi.nlm.nih.gov/pubmed/28356718
http://dx.doi.org/10.2147/DDDT.S121899

Ejemplares similares